SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-18-000672
Filing Date
2018-02-14
Accepted
2018-02-14 07:57:51
Documents
95
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bivv-20171231x10k.htm 10-K 3054020
2 EX-23.1 bivv-20171231ex2318c9749.htm EX-23.1 2525
3 EX-31.1 bivv-20171231ex311bd94bc.htm EX-31.1 11737
4 EX-31.2 bivv-20171231ex31236a75e.htm EX-31.2 11773
5 EX-32.1 bivv-20171231ex321e3749c.htm EX-32.1 10537
6 GRAPHIC bivv20171231x10k001.jpg GRAPHIC 9867
7 GRAPHIC bivv20171231x10k002.jpg GRAPHIC 6252
8 GRAPHIC bivv20171231x10k003.jpg GRAPHIC 5684
9 GRAPHIC bivv20171231x10k004.jpg GRAPHIC 16238
10 GRAPHIC bivv20171231x10k005.jpg GRAPHIC 16721
  Complete submission text file 0001558370-18-000672.txt   11091202

Data Files

Seq Description Document Type Size
11 EX-101.INS bivv-20171231.xml EX-101.INS 2499549
12 EX-101.SCH bivv-20171231.xsd EX-101.SCH 63207
13 EX-101.CAL bivv-20171231_cal.xml EX-101.CAL 82420
14 EX-101.DEF bivv-20171231_def.xml EX-101.DEF 246536
15 EX-101.LAB bivv-20171231_lab.xml EX-101.LAB 631583
16 EX-101.PRE bivv-20171231_pre.xml EX-101.PRE 478377
Mailing Address 225 2ND AVENUE WALTHAM MA 02451
Business Address 225 2ND AVENUE WALTHAM MA 02451 781-663-4400
Bioverativ Inc. (Filer) CIK: 0001681689 (see all company filings)

IRS No.: 813461310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37859 | Film No.: 18607181
SIC: 2834 Pharmaceutical Preparations